Ontario Teachers Pension Plan Board Grows Holdings in Encompass Health Corporation $EHC

Ontario Teachers Pension Plan Board lifted its stake in shares of Encompass Health Corporation (NYSE:EHC) by 9.8% in the second quarter, HoldingsChannel.com reports. The fund owned 24,051 shares of the company’s stock after acquiring an additional 2,137 shares during the quarter. Ontario Teachers Pension Plan Board’s holdings in Encompass Health were worth $2,949,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. Pinnacle Wealth Planning Services Inc. boosted its holdings in shares of Encompass Health by 4.0% in the 1st quarter. Pinnacle Wealth Planning Services Inc. now owns 2,597 shares of the company’s stock worth $263,000 after purchasing an additional 99 shares in the last quarter. Securian Asset Management Inc. grew its position in Encompass Health by 1.3% during the second quarter. Securian Asset Management Inc. now owns 7,716 shares of the company’s stock valued at $946,000 after acquiring an additional 100 shares during the last quarter. State of Michigan Retirement System raised its stake in shares of Encompass Health by 0.4% during the second quarter. State of Michigan Retirement System now owns 24,245 shares of the company’s stock worth $2,973,000 after acquiring an additional 100 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Encompass Health by 19.0% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after acquiring an additional 115 shares during the last quarter. Finally, UMB Bank n.a. boosted its stake in shares of Encompass Health by 10.9% in the 2nd quarter. UMB Bank n.a. now owns 1,187 shares of the company’s stock valued at $146,000 after purchasing an additional 117 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Price Performance

EHC stock opened at $113.49 on Friday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The firm has a market capitalization of $11.42 billion, a price-to-earnings ratio of 21.45, a PEG ratio of 2.20 and a beta of 0.91. The firm has a 50 day moving average price of $122.64 and a 200-day moving average price of $119.69. Encompass Health Corporation has a 52-week low of $87.85 and a 52-week high of $127.99.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%.The business had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Equities research analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be given a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Friday, January 2nd. Encompass Health’s dividend payout ratio is 14.37%.

Insiders Place Their Bets

In related news, EVP Patrick William Tuer sold 1,020 shares of the company’s stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the transaction, the executive vice president directly owned 18,846 shares of the company’s stock, valued at approximately $2,329,177.14. This represents a 5.13% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 2.00% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. Barclays boosted their price target on shares of Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a research note on Thursday, October 30th. Truist Financial lifted their price target on Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a research note on Thursday, August 14th. Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. UBS Group increased their price target on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Thursday, October 2nd. Finally, Raymond James Financial raised shares of Encompass Health to a “strong-buy” rating in a research note on Friday, October 31st. Three investment analysts have rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the company’s stock. According to data from MarketBeat.com, Encompass Health has an average rating of “Buy” and an average price target of $142.86.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.